EUVIMEDEUVIMED entdecken
Crossref

Screening for Pompe Disease in High-Risk Pediatric Patients: Experience from a Tertiary Care Center in Rajasthan

Tuhina Nagpal, Manisha Goyal, Priyanshu Mathur, Kamlesh Kumar Agrawal, Ashok Gupta

Journal of Pediatric Neurology · 01.02.2024 · 22 (01) · 037-043

DOI: 10.1055/s-0043-57241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Neurology, erschienen am 01.02.2024. Verfasst von Tuhina Nagpal und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A high index of suspicion is required to diagnose rare genetic disorders, such as Pompe disease, with common clinical manifestations in children. There is a need to sensitize physicians regarding cues to early screening and diagnosis of such patients. Minimal epidemiological data are available on Pompe disease in India. The aim of this study was to determine the prevalence of Pompe disease in high-risk pediatric populations and determine the appropriateness of screening dried blood spot (DBS) tests to facilitate the diagnosis of Pompe disease. We screened pediatric patients presented with (1) unexplained hypotonia, respiratory distress, cardiomyopathy, and elevated liver function tests; and (2) unexplained limb girdle muscle weakness through a DBS test for enzyme assay. Those patients found positive underwent acid alpha-glucosidase mutational analysis. This prospective cross-sectional study was conducted in 45 suspected patients after approval from the institutional ethical committee. Of the 45 suspected patients, 9 (20%) were found to be positive by DBS test. Out of these nine tested, four (44.4%) were positive, two (22.2%) were negative, and three (33.3%) could not be tested for mutation analysis. The prevalence of genetically confirmed Pompe disease in high-risk populations was 8.8%. The results of this study show that clinical suspicion and DBS filter paper test facilitate early diagnosis and management, thereby improving the quality of life in patients. DBS test acts as a robust, rapid first-tier screening test for Pompe disease.

Zitieren

APA

Nagpal, T., Goyal, M., Mathur, P., Agrawal, K. K., & Gupta, A. (2024). Screening for Pompe Disease in High-Risk Pediatric Patients: Experience from a Tertiary Care Center in Rajasthan. Journal of Pediatric Neurology, 22(01), 037-043. https://doi.org/10.1055/s-0043-57241

Vancouver

Nagpal T, Goyal M, Mathur P, Agrawal KK, Gupta A. Screening for Pompe Disease in High-Risk Pediatric Patients: Experience from a Tertiary Care Center in Rajasthan. Journal of Pediatric Neurology. 2024;22(01):037-043. doi:10.1055/s-0043-57241

BibTeX
@article{Nagpal2024,
  author = {Nagpal, Tuhina and Goyal, Manisha and Mathur, Priyanshu and Agrawal, Kamlesh Kumar and Gupta, Ashok},
  title = {Screening for Pompe Disease in High-Risk Pediatric Patients: Experience from a Tertiary Care Center in Rajasthan},
  journal = {Journal of Pediatric Neurology},
  year = {2024},
  volume = {22},
  number = {01},
  pages = {037--043},
  doi = {10.1055/s-0043-57241}
}
Kostenlos starten →